Investment analysts at Leerink Partnrs cut their Q4 2024 earnings estimates for Bristol-Myers Squibb in a research report issued on Monday, November 4th. Leerink Partnrs analyst D. Risinger now ...

Equities researchers at Leerink Partnrs decreased their Q3 2024 EPS estimates for Bristol-Myers Squibb in a research report ...

Hyatt Hotels Corporation ("Hyatt" or the "Company") today reported third quarter 2024 results. Highlights include: Comparable system-wide hotels RevPAR increased 3.0% compared to the same period in ...

This is an audio transcript of the Behind the Money podcast episode: ‘An activist tried to take on Pfizer. Then things got ...

Pharmaceutical giant Bristol Myers Squibb (BMY) raises its full-year earnings guidance after topping third quarter estimates, sending shares higher in pre-market trading. Concurrently, Merck & Co ...

The agency noted that the inauguration of the BMS State teams is also a reflection of the agency’s renewed efforts to implement and enforce the International Code of Marketing of Breastmilk ...

AP Medical Writer Some people who took a new schizophrenia drug for one year improved with only a few side effects, but many dropped out of the research. That’s according to company-sponsored studies ...

Layoffs sharply decreased between the first and second halves of the year, painting a fairly optimistic economic picture for the county, despite relatively flat venture capital funding levels last ...

The Inhibition of Metallo Protease by BMS-186716 in a Randomized Exercise and Symptoms Study in Subjects With Heart Failure (IMPRESS) trial [6] randomized patients with congestive heart failure to ...